Clearside Biomedical Inc (CLSD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Clearside Biomedical Inc-Aktie (CLSD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	78.88% 0.492	2.33	0.306	1.038	0.09
Cost Of Revenue	100.00% -	0.248	0.149	-	-
Gross Profit	76.37% 0.492	2.082	-	-	-
Operating Expenses	44.28% 4.06	7.287	7.306	6.972	7.68
Benefits Costs and Expenses	49.31% 4.987	9.838	7.612	-	-
Costs And Expenses	49.31% 4.987	9.838	7.612	6.972	7.68
Operating Income/Loss	31.45% -3.568	-5.205	-7.149	-5.934	-7.59
Income/Loss From Continuing Operations Before Tax	40.13% -4.495	-7.508	-7.306	1.038	-7.595
Income Tax Expense/Benefit	100.00% -	0.715	-	-	-
Income/Loss From Continuing Operations After Tax	45.34% -4.495	-8.223	-7.306	-7.688	-7.595
Net Income/Loss	45.34% -4.495	-8.223	-7.306	-7.688	-7.595
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.20% 77.84	76.92	0.6875	74.75	74.73
Diluted Average Shares	1.20% 77.84	76.92	0.6875	74.75	74.73
Basic Earnings Per Share	45.45% -0.06	-0.11	-0.10	-0.10	-0.10
Diluted Earnings Per Share	45.45% -0.06	-0.11	-0.10	-0.10	-0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$24.78

0.98%

INCY

$84.84

1.00%

SMMT

$24.80

8.06%

BNTX

$103.01

1.70%

INSM

$134.53

1.79%

ONC

$300.14

2.84%